Health and Healthcare

Cramer Calls Hansen Medical the Next Intuitive Surgical

On CNBC’s MAD MONEY, Cramer said he is unveiling a medical delivery technology company and will be doing this as part of a new series.  He is reviewing Hansen Medical (HNSN-NASDAQ), but you have to be careful because it is a very small cap stock and you’ll need one of their catheters if you are jumping in after-hours trading and you should wait a couple or few days.  He thinks this could be the next Intuitive Surgical (ISRG).  This is in the non-pharma healthcare sector and will be partially immune to democratic attempts to take away profits from drug companies.  The company makes robotic catheter systems that doctors and nurses don’t have the same issues with in regular catheters.  They are targeting patients with irregular heart beats and there are more than 5 million people with this in the US.  He thinks the product will be approved in the EU first in the first half of this year, and then he thinks it will be approved in the second half of the year here in the US.  Stereotaxis (STXS) is the only competitor and Hansen’s machines are cheaper.  Intuitive Surgical (ISRG) co-founders are the founders of Hansen and those guys have a monster track record with more than a 1,000% return since coming public.

Jon C. Ogg
March 12, 2007

Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.

Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)

If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.

Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.